Thus, AKT3-174aa exerted a tumour-suppressive role in GBM by acting as negative regulator of AKT activity, leading to significant reduction in cell proliferation, clonogenic activity and radiation resistance [175]. The gene discussed is AKT3; the disease is glioblastoma.